These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 36325684)

  • 1. The quantitative evaluation of retinal layers after resolution of subretinal fluid in acute central serous chorioretinopathy.
    Dursun E; Dursun GA
    Eur J Ophthalmol; 2022 Nov; ():11206721221136989. PubMed ID: 36325684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of Retinal Layer Thickness and Capillary Vessel Density in the Patients with Spontaneously Resolved Acute Central Serous Chorioretinopathy.
    Han KJ; Kim HJ; Woo JM; Min JK
    J Clin Med; 2020 Dec; 10(1):. PubMed ID: 33375674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long term outer retinal changes in central serous chorioretinopathy submitted to half-dose photodynamic therapy.
    Torres-Costa S; Penas S; Cerqueira AR; Brandão E; Carneiro Â; Rocha-Sousa A; Falcão-Reis F
    Photodiagnosis Photodyn Ther; 2021 Jun; 34():102235. PubMed ID: 33631379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microstructural changes after half-dose photodynamic therapy in patients with chronic central serous chorioretinopathy.
    Esen E; Sizmaz S; Demircan N
    Photodiagnosis Photodyn Ther; 2021 Sep; 35():102347. PubMed ID: 34033938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. One-year results of reduced fluence photodynamic therapy for central serous chorioretinopathy: the outer nuclear layer thickness is associated with visual prognosis.
    Ohkuma Y; Hayashi T; Sakai T; Watanabe A; Tsuneoka H
    Graefes Arch Clin Exp Ophthalmol; 2013 Aug; 251(8):1909-17. PubMed ID: 23456099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Morphologic changes and visual outcomes in resolved central serous chorioretinopathy treated with ranibizumab.
    Ozdemir O; Erol MK
    Cutan Ocul Toxicol; 2014 Jun; 33(2):122-6. PubMed ID: 23848591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation between outer retinal layer thickness and cone density in patients with resolved central serous chorioretinopathy.
    Nakamura T; Ueda-Consolvo T; Oiwake T; Hayashi A
    Graefes Arch Clin Exp Ophthalmol; 2016 Dec; 254(12):2347-2354. PubMed ID: 27255458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors of persistent subretinal fluid after half-dose photodynamic therapy for treatment-naïve central serous chorioretinopathy.
    Li M; Qu J; Liang Z; Tang J; Hu J; Yao Y; Jin E; Li X; Zhao M
    Graefes Arch Clin Exp Ophthalmol; 2022 Jul; 260(7):2175-2182. PubMed ID: 35024912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Photoreceptor outer segment layer thinning as a biomarker in acute central serous chorioretinopathy.
    Maltsev DS; Kulikov AN; Burnasheva MA; Chhablani J
    Ther Adv Ophthalmol; 2023; 15():25158414231160689. PubMed ID: 36970709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in the Foveal Outer Nuclear Layer of Central Serous Chorioretinopathy Patients Over the Disease Course and Their Response to Photodynamic Therapy.
    Deng K; Gui Y; Cai Y; Liang Z; Shi X; Sun Y; Zhao M
    Front Med (Lausanne); 2021; 8():824239. PubMed ID: 35096914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Multimodal Approaches for the Analysis of Retinal Functional Disorders―Focusing on Retinal Detachment].
    Terasaki H
    Nippon Ganka Gakkai Zasshi; 2017 Mar; 121(3):185-231. PubMed ID: 30088405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of Subretinal Fluid Duration and Baseline Chorioretinal Structure With Optical Coherence Tomography in Central Serous Chorioretinopathy.
    Suzuki T; Sasajima H; Otaki C; Ueta Y; Tate H
    Transl Vis Sci Technol; 2023 Oct; 12(10):12. PubMed ID: 37831445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relationship between foveal outer nuclear layer thickness in the active and resolved phases of central serous chorioretinopathy treated with half-dose photodynamic therapy.
    Yu J; Lei Y; Chang Q; Xu G; Ye X; Li L; Jiang C
    BMC Ophthalmol; 2019 Mar; 19(1):84. PubMed ID: 30922273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optical Coherence Tomography Parameters as Predictors of Treatment Response to Eplerenone in Central Serous Chorioretinopathy.
    Borrelli E; Zuccaro B; Zucchiatti I; Parravano M; Querques L; Costanzo E; Sacconi R; Prascina F; Scarinci F; Bandello F; Querques G
    J Clin Med; 2019 Aug; 8(9):. PubMed ID: 31443376
    [No Abstract]   [Full Text] [Related]  

  • 15. Anatomical Retinal Changes after Photodynamic Therapy in Chronic Central Serous Chorioretinopathy.
    Ruiz-Del-Tiempo MP; Calvo P; Ferreras A; Leciñena J; Pablo L; Ruiz-Moreno O
    J Ophthalmol; 2018; 2018():4081874. PubMed ID: 29545952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation of spectral domain optical coherence tomography findings in acute central serous chorioretinopathy with visual acuity.
    Nair U; Ganekal S; Soman M; Nair K
    Clin Ophthalmol; 2012; 6():1949-54. PubMed ID: 23225998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outer nuclear layer thickness at the fovea determines visual outcomes in resolved central serous chorioretinopathy.
    Matsumoto H; Sato T; Kishi S
    Am J Ophthalmol; 2009 Jul; 148(1):105-10.e1. PubMed ID: 19327740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BASELINE SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHIC RETINAL LAYER FEATURES IDENTIFIED BY ARTIFICIAL INTELLIGENCE PREDICT THE COURSE OF CENTRAL SEROUS CHORIORETINOPATHY.
    Ferro Desideri L; Anguita R; Berger LE; Feenstra HMA; Scandella D; Sznitman R; Boon CJF; van Dijk EHC; Zinkernagel MS
    Retina; 2024 Feb; 44(2):316-323. PubMed ID: 37883530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Half-Fluence Photodynamic Therapy for Chronic Central Serous Chorioretinopathy: Predisposing Factors for Visual Acuity Outcomes.
    Matušková V; Vysloužilová D; Uher M
    Semin Ophthalmol; 2018; 33(5):690-699. PubMed ID: 29252091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Focal Laser Photocoagulation on the Ganglion Cell Complex Thickness in Acute Central Serous Chorioretinopathy.
    Lee AY; Choi J; Lee SU; Kim CW; Hwang DD
    J Clin Med; 2024 Feb; 13(4):. PubMed ID: 38398376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.